Quick Listen: Scrip's Five Must-Know Things

 
• By Ian Haydock

In this week's podcast edition of Five Must-Know Things: making cell and gene therapies more accessible; Roche’s obesity plans; BIOSECURE and Indian firms; IPOs begin to recover; and Nxera looks to the future.

Scrip Five Must Know Things
weekly audio roundup of selected content from Scrip's global team

More from Business

More from Scrip